Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection

被引:104
|
作者
Segal, BH
Barnhart, LA
Anderson, VL
Walsh, TJ
Malech, HL
Holland, SM
机构
[1] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA
[2] Roswell Pk Canc Inst, Dept Med, Div Infect Dis, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Dept Immunol, Div Infect Dis, Buffalo, NY 14263 USA
[4] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
[5] NCI, Immunocompromised Host Sect, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1086/430068
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic granulomatous disease (CGD) is characterized by life-threatening bacterial and fungal infections. Treatment with posaconazole led to a complete response in 7 of 8 patients with CGD with invasive mold infections ( 7 proven cases and 1 possible case) after failure or intolerance of treatment with standard antifungal agents. In this preliminary study, salvage treatment with posaconazole was safe and effective.
引用
收藏
页码:1684 / 1688
页数:5
相关论文
共 50 条
  • [41] Posaconazole prophylaxis - impact on incidence of invasive fungal disease and antifungal treatment in haematological patients
    Peterson, Lisa
    Ostermann, Julia
    Rieger, Heidi
    Ostermann, Helmut
    Rieger, Christina Theresa
    MYCOSES, 2013, 56 (06) : 651 - 658
  • [42] Efficacy and safety of posaconazole in hematopoietic stem cell transplantation patients with invasive fungal disease
    Zhang, Sudong
    He, Yi
    Jiang, Erlie
    Wei, Jialin
    Yang, Donglin
    Zhang, Rongli
    Zhai, Weihua
    Zhang, Guixin
    Wang, Zhao
    Zhang, Lining
    Liu, Li
    Han, Mingzhe
    Feng, Sizhou
    FUTURE MICROBIOLOGY, 2017, 12 (15) : 1371 - 1379
  • [43] Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection
    Ullmann, AJ
    Cornely, OA
    Burchardt, A
    Hachem, R
    Kontoyiannis, DP
    Töpelt, K
    Courtney, R
    Wexler, D
    Krishna, G
    Martinho, M
    Corcoran, G
    Raad, I
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 658 - 666
  • [44] Pulmonary fungal infection diagnosis in chronic granulomatous disease patients (vol 42, pg 851, 2007)
    Sierre, Sergio
    Lipsich, Jose
    Santos, Patricia
    Hernandez, Claudia
    Siminovich, Monica
    Oleastro, Matias
    Zelazko, Marta
    Rosenzweig, Sergio D.
    PEDIATRIC PULMONOLOGY, 2007, 42 (10) : 987 - 987
  • [45] Invasive fungal infection following venetoclax and posaconazole co-administration
    Reynolds, Gemma
    Urbancic, Karen F.
    Fong, Chun Y.
    Trubiano, Jason A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (04) : 593 - 598
  • [46] Chronic Granulomatous Disease: A Study of Two Cases with Fungal Infection in Early Infancy
    Karbasian, Fereshteh
    Khanbabaei, Ghamartaj
    Armin, Shahnaz
    Mesdaghi, Mehrnaz
    Zafari, Ali
    Shahrbabaki, Zahra Salehi
    Chavoshzadeh, Zahra
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2018, 31 (02) : 116 - 118
  • [47] Mulch pneumonitis in chronic granulomatous disease: More than just a fungal infection
    Soomann, Maarja
    Prader, Seraina
    Gungor, Tayfun
    Schmid, Jana Pachlopnik
    Warris, Adilia
    Trueck, Johannes
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2024, 35 (12)
  • [48] INFECTION AND CHRONIC GRANULOMATOUS DISEASE
    GLEZEN, WP
    JOURNAL OF PEDIATRICS, 1974, 84 (01): : 160 - 161
  • [49] Is there an interest of new techniques for dosing posaconazole in invasive fungal infection prophylaxis?
    Gabellier, L.
    Vincent, M.
    Mathieu, O.
    Hicheri, Y.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S393 - S394
  • [50] Chronic invasive fungal rhinosinusitis and granulomatous invasive fungal sinusitis: A systematic review of symptomatology and outcomes
    Bahethi, Rohini
    Talmor, Guy
    Choudhry, Hannaan
    Lemdani, Mehdi
    Singh, Priyanka
    Patel, Rushi
    Hsueh, Wayne
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (01)